Back to search
Siewert Type II Adenocarcinoma of the Esophagogastric Junction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Siewert Type II Adenocarcinoma of the Esophagogastric Junction trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Siewert Type II Adenocarcinoma of the Esophagogastric Junction trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Proximal gastric and esophagogastric junction cancers comprise up to 40% of gastric malignancies. For localized disease, proximal gastrectomy is the main radica…
The incidence of esophagogastric junction has been increasing in recent years, and surgery is an important method for the treatment of adenoma at the esophagoga…
To explore the 5-year overall survival (OS) of right versus left thoracic surgical approaches for patients with locally advanced Siewert II gastroesophageal jun…
Mediastinal lymph node dissection has been adopted as standard treatment for adenocarcinoma of esophagogastric junction(AEJ). This multi-center, exploratory, pr…
Evaluating the efficacy and safety of SHR-1701 combined with chemotherapy for the perioperative treatment of locally advanced resectable Siewert type II adenoca…
This interventional clinical trial aims to find ways of improving treatments for individuals with esophageal cancer. Laboratory-based studies show that using me…